ArticleInfection and immunity2003

Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability.

Susana Mendez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.